UFC women’s flyweight Jennifer Maia has accepted a six-month suspension from USADA due to a positive drug test that resulted from a contaminated supplement.
The Las Vegas-based promotion released a statement on the situation on Tuesday. In on out-of-competition test conducted on Aug. 16, Maia tested positive for multiple banned substances — furosemide, hydrochlorothiazide, chlorothiazide, and the thiazide metabolite 4-amino-6-chloro-1,3-benzenedisulfonamide (ACB) — all of which fall into the category of diuretics and masking agents.
“During an investigation into the circumstances of her case, opened and sealed containers of a dietary supplement she was using at the time of the August 16, 2018 sample collection, and that she declared on her doping control form, were sent to the WADA-accredited laboratory in Brazil for analysis,” the statement read.”Although no prohibited substances were listed on the supplement label, the analysis revealed that both contained the prohibited substances for which Maia tested positive.”
Maia’s suspension is retroactive to Aug. 31, so she will be able to return to UFC competition in March. The former Invicta FC 125-pound queen made her Octagon debut at UFC Fight Night 133, where she suffered a unanimous decision loss to Liz Carmouche on July 14.